Catalent

Catalent.jpg

Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health products and global clinical supply services. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,000 people, including over 1,000 scientists, at nearly 30 facilities across 5 continents and in fiscal 2014 generated more than $1.8 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit www.catalent.com

More products. Better treatments. Reliably supplied.™

Related Resources

Process optimization for mAb commercial manufacturing

Process optimization for mAb commercial manufacturing

Content provided by Catalent

Product Brochure

Process characterization and validation is an important step in the product development journey and late-phase development, and it is required before transferring an existing manufacturing process.

Considerations for Process Characterization of Biologics

Considerations for Process Characterization of Biologics

Content provided by Catalent

Insight Guide

Process characterization is an important step in the product development journey. Download this Q&A article to learn the latest trends, status, and insights into process characterization and validation of monoclonal antibodies and recombinant proteins.

Create Better Biologic Treatments with Catalent

Create Better Biologic Treatments with Catalent

Content provided by Catalent

Product Brochure

Deliver safe and stable products to your patients with the help of Catalent Biologics' Limoges, France site, a European Center of Excellence for early-phase clinical biologics formulation development and drug product fill/finish. It offers an integrated...